The Effectiveness of the Treatment of Patients with Benign and Malignant Neoplasms of the Skin with the Ointment “Antineoderm C-A”

Introduction. In all countries of the world, in particular in Ukraine, there is a significant increase in the incidence rate of the tumors of the skin, the prevention and treatment of which has a significant medical, social and economic significance. In clinical practice, different methods of treatment of benign and malignant neoplasms of the skin are used, among which surgical method, laser and electrocoagulation, cryodestruction using liquid nitrogen, ointment based on concentrated alkali and acids, etc., have been widely used. The statistical indicators of evaluating their efficacy indicate that good, long-term results of the treatment of malignant neoplasms of the skin are achieved only in 15.0-25.0% of patients. The search for new, more effective methods of treating this category of patients deserves special attention. The aim of this work is to find out the effectiveness of the treatment with herbal liniment “Antineoderm C-A” in patients with benign and malignant neoplasms of the skin. Material and methods. For 28 years we have examined and cured 20221 patients with different benign and malignant neoplasms (8 214 (40.62%) men, 12007 (59.38%) of women), aged 3 to 93 years. Of these, 329 (1.63%) patients with early melanoma and 118 (0.58%) patients with squamous cell carcinoma of the skin, which until now have not been treated, 1024 (5.06%) patients with a diagnosis of “basal cell carcinoma of the skin” , In which there was a relapse of the disease after the traditional methods of “removal” in other clinics. Of the 16335 patients (80.78%) with benign neoplasms, 7350 (45.00%) were not helped by other methods of treatment. The following survey methods have been used: visual inspection with dandruff, dermatoscopy, biopsy in cases of benign tumors of the skin (to clarify the diagnosis) with subsequent histological and pathomorphological studies of biopsy. In patients with early stages of melanoma (a biopsy is categorically banned because it can lead to traumatic metastasis of the tumor), a specific oncologic marker, S-100 melanoma protein, has been identified that can detect the presence of metastases. For the patients with melanomas in the early stages it was performed a comprehensive clinical-laboratory and instrumental examination of the internal organs for detecting the presence of metastases in accordance with approved protocols of the Ministry of Public Health of Ukraine. Results. In the vast majority of the treated patients there were no unsatisfactory direct results of supervision. The treatment proceeded without complications, except for the patients with plantar warts, which failed to complete the curia because of their refusal from the necessary in this case numerous medical sessions. Among 2349 (100.00%) of patients with different types of warts in 2344 (99.78%) the treatment was good, and unsatisfactory result was observed in 5 (0.22%) patients with plantar warts due to reluctance to continue treatment. And the among the total number of treated patients (20221-100.00%) poor results were observed in 0.02% of patients. Patients with good results of treatment include those 1024 patients with basal cell carcinoma of the skin and 7350 patients with benign neoplasms, who had signs of relapse after applying other methods (surgical, laser and electrocoagulation, cryodestruction using liquid nitrogen, using an ointment based on concentrated alkalis and acids, etc.). Conclusions. Treatment of benign and malignant tumors and melanoma in early stages using “Antyneoderm C-A” is safe and effective, and therefore, regardless of gender and age can be recommended for use in dermatooncology.